Resilience
Pre-clinicalResilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing.
Founded
2020
Focus
BiologicsCell TherapyGene Therapy
About
Resilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing.
Funding History
4Total raised: $2.6B
Series D$625MTPGJun 15, 2022
Series C$625MTPGAug 15, 2021
Series B$600MViking Global InvestorsMar 15, 2021
Series A$800MARCH Venture PartnersNov 15, 2020
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile